Kate Ryder headlines Women’s Health Week USA 2026 as full agenda goes live

Women’s Health Week USA 2026 has unveiled its first populated agenda, anchored by an opening keynote from Kate Ryder, Founder and CEO of Maven Clinic, and featuring a cross-sector lineup shaping the next phase of scale in women’s health.
You can view the full agenda here.
Taking place May 13–14, 2026, at the New York Academy of Medicine, Women’s Health Week USA brings together the full women’s health ecosystem to focus on one central question: what does it take to move women’s health from innovation to institutional scale?
Kate Ryder will open Day 1 with a keynote drawing on her experience building Maven Clinic into the world’s largest virtual clinic for women’s and family health.
Under her leadership, Maven has partnered with employers and health plans to deliver care across fertility, maternity, postpartum, paediatrics, and menopause at scale.
Her perspective sets the tone for a program centered on commercialisation, partnership, and sustainable growth.
Beyond the opening keynote, the newly released agenda reflects the sector’s growing maturity.
Across two days, the program features 70+ speakers, with representation from leading organizations including the FDA, Planned Parenthood, CVS Health Ventures, Samsung Next, NIH, WHO, and Maven Clinic.
Sessions span investment and deal flow, clinical innovation, regulation, data and technology, and market expansion, alongside dedicated pitch sessions and curated 1:1 matchmaking designed to turn insight into action.
The agenda has been built to facilitate meaningful connections across the ecosystem, with partnerships positioned as the primary driver of scale.
As women’s health continues to attract institutional capital and global attention, Women’s Health Week USA 2026 offers a clear snapshot of where the market is heading, and who is shaping it.
The full agenda is now live, with additional speakers and partners to be announced in the coming months.
View the full programme here.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.







